Ursula Kaiser-Vehling

Landshut, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

What Social and Therapeutic Services Should a Day Hospice Provide for Patients? A Cohort Study from the Perspective of Patients and Their Relatives.

What Social and Therapeutic Services Should a Day Hospice Provide for Patients? A Cohort Study from the Perspective of Patients and Their Relatives.

Journal: Journal of palliative medicine

Published: August 04, 2026

Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.

Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: March 17, 2026

Ibrutinib for early-stage CLL: genetic risk factors and treatment outcome in the GCLLSG CLL12 trial.

Ibrutinib for early-stage CLL: genetic risk factors and treatment outcome in the GCLLSG CLL12 trial.

Journal: Blood

Published: December 23, 2025

Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trial.

Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trial.

Journal: Blood

Published: December 23, 2025

IGLV3-21R110 and ibrutinib treatment: Results from the double-blind, randomized, placebo-controlled GCLLSG CLL12 trial in early-stage CLL.

IGLV3-21R110 and ibrutinib treatment: Results from the double-blind, randomized, placebo-controlled GCLLSG CLL12 trial in early-stage CLL.

Journal: HemaSphere

Published: December 05, 2025

Influence of a day hospice on the quality of life of palliative care patients: an interview-based qualitative survey.

Influence of a day hospice on the quality of life of palliative care patients: an interview-based qualitative survey.

Journal: BMC palliative care

Published: November 09, 2025

Experts' attitudes towards 'targeted autopsies' using qualitative interviews in a medical network in Germany.

Experts' attitudes towards 'targeted autopsies' using qualitative interviews in a medical network in Germany.

Journal: BMJ open

Published: October 21, 2025

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.

Journal: Haematologica

Published: October 17, 2025

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.

Journal: Haematologica

Published: October 17, 2025

Vulnerability to Infections and Secondary Immunodeficiencies in Patients with Non-Hodgkin's Lymphomas Starting Anti-CD20 Antibody-Containing Therapies.

Vulnerability to Infections and Secondary Immunodeficiencies in Patients with Non-Hodgkin's Lymphomas Starting Anti-CD20 Antibody-Containing Therapies.

Journal: Oncology research and treatment

Published: August 18, 2025

Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance).

Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance).

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 05, 2025

Super-Resolution Contrast-Enhanced Ultrasound Examination Down to the Microvasculature Enables Quantitative Analysis of Liver Lesions: First Results.

Super-Resolution Contrast-Enhanced Ultrasound Examination Down to the Microvasculature Enables Quantitative Analysis of Liver Lesions: First Results.

Journal: Life (Basel, Switzerland)

Published: April 30, 2025

Showing 1-12 of 84

Last Updated: 09/26/2026